They sold fifteen million genomes. We never hold yours.

What happened

23andMe filed for Chapter 11 bankruptcy in 2025. Its database (around fifteen million genetic profiles, the largest private genomic dataset ever built) was treated as an ordinary corporate asset and sold. That episode settled an uncomfortable question out loud: when a consumer-genetics company collects and stores your DNA, your most permanent, most familial data can end up owned by whoever buys the company.

Genetic data isn't like an email address. You can't change it, and it isn't only yours. It reveals information about your parents, siblings and children too. Handing it to a company to hold is a decision with a very long tail.

Why Aimosti is structurally different

We don't run that model. There is no Aimosti DNA vault to be sold, because the architecture removes the thing that gets sold:

• Bring your own genome. We never take a sample or sequence anything. You upload data you already own; you keep the file. We re-analyse it.
• EU-sovereign. Your data is processed and stored in Finland and never leaves the European Union, under GDPR Article 9 special-category protection.
• Raw input is ephemeral. We delete your raw upload after analysis by default; subscribers keep only a small normalised variant file, and only with explicit, withdrawable consent.
• Never sold, never mined, never used to train AI. Our business is the report, not your genome.

And if Aimosti itself shuts down?

This is the question 23andMe taught everyone to ask, so here is the plain answer. We never sell your data. A company can change hands; your genome data is never part of any such deal and stays bound by this same privacy promise. If we ever wind the service down, our commitment is export-first, then deletion: you get the chance to export what's yours, and then it is permanently deleted. Because we hold so little to begin with (your last report snapshot and, only for subscribers, a small variant file), there is very little to wind down, and you can delete everything on demand at any time before that.

Have a non-diagnostic genome gathering dust?

If a hospital or clinical geneticist sequenced you, handed back an inconclusive report and discharged you, that file is still yours, and the databases have not stood still. ClinVar, ACMG and CPIC move every month. Aimosti re-matches your existing VCF against the current evidence and flags what changed since it was first read. We name, in plain words, what your file can and cannot show. See a sample report →